3/10/2022 Assessing the impact of the COVID-19 pandemic on emergency department use for patients undergoing cancer-directed surgeries Eskander A, Li Q, Yu J, Hallet J, Coburn N, Dare A, Chan KKW, Singh S, Parmar A, Earle CC, Lapointe-Shaw L, Krzyzanowska MK, Hanna TP, Finelli A, Louie AV, Look-Hong N, Irish JC, Witterick I, Mahar A, Urbach DR, Enepekides D, Sutradhar R; on behalf of the Pandemic—Ontario Collaborative in Cancer Research (POCCR). Curr Oncol. 2022; 29(3):1877-89. Epub 2022 Mar 10. DOI: https://doi.org/10.3390/curroncol29030153
2/1/2022 Incident cancer detection during the COVID-19 pandemic Eskander A, Li Q, Yu J, Hallet J, Coburn NG, Dare A, Chan KKW, Singh S, Parmar A, Earle CC, Lapointe-Shaw L, Krzyzanowska MK, Hanna TP, Finelli A, Louie AV, Look Hong N, Irish JC, Witterick IJ, Mahar A, Noel CW, Urbach DR, McIsaac DI, Enepekides D, Sutradhar R. J Natl Compr Canc Netw. 2022; 20(3):276-84. Epub 2022 Feb 1. DOI: https://doi.org/10.6004/jnccn.2021.7114
6/4/2021 Risk of cancer-specific death for patients diagnosed with neuroendocrine tumors: a population-based analysis Hallet J, Law C, Singh S, Mahar A, Myrehaug S, Zuk V, Zhao H, Chan W, Assal A, Coburn N. J Natl Compr Canc Netw. 2021; 19(8):935-44. Epub 2021 Jun 4. DOI: https://doi.org/10.6004/jnccn.2020.7666
The Globe and Mail11/5/2018Article Additional screening for late-stage cancer patients has little benefit, study says